Cargando…
The Relationship between Plasma Pentraxin 3 and Serum Amyloid P Levels and Disease Activity in Ankylosing Spondylitis
BACKGROUND: In clinical practice, it is hard to judge the level of disease activity in some patients with ankylosing spondylitis (AS) who have low traditional acute phase reactant values such as erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) but have considerable pain and inflamma...
Autores principales: | Özdemirel, Ali Erhan, Güven, Serdar Can, Sunar, İsmihan, Sari Sürmeli, Zühre, Doğanci, Alper, Tutkak, Hüseyin, Yalçin Sayin, Ayşe Peyman, Ataman, Şebnem |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9159165/ https://www.ncbi.nlm.nih.gov/pubmed/35685583 http://dx.doi.org/10.1155/2022/7243399 |
Ejemplares similares
-
Anti-tumor necrosis factor alpha treatment does not influence serum levels of the markers associated with radiographic progression in ankylosing spondylitis
por: Özdemirel, Ali Erhan, et al.
Publicado: (2023) -
Serum BMP-2 and BMP-4 levels and their relationship with disease activity in patients with rheumatoid arthritis and ankylosing spondylitis
por: Özdemirel, Ali Erhan, et al.
Publicado: (2022) -
Biomarkers of Cardiovascular Disease in Patients With Ankylosing Spondylitis
por: SARP, Ümit, et al.
Publicado: (2020) -
Association of Genetic Variants in Pentraxin 3 Gene with Ankylosing Spondylitis
por: Zhang, Xu, et al.
Publicado: (2016) -
Anti-rheumatic treatment is not associated with reduction of pentraxin 3 in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis
por: Deyab, Gia, et al.
Publicado: (2017)